![Jay Mitchell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Mitchell
Chief Tech/Sci/R&D Officer at
CLIMB BIO, INC.
Profile
Jay Mitchell is Vice President-Clinical Operations at Climb Bio, Inc. since 2024.
Education includes an undergraduate degree from the University of Memphis and an MBA from the University of Mississippi.
Jay Mitchell active positions
| Companies | Position | Start |
|---|---|---|
| CLIMB BIO, INC. | Chief Tech/Sci/R&D Officer | 2024-06-30 |
Training of Jay Mitchell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
25
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Memphis
 University of Memphis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mississippi
 University of Mississippi Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eliem Therapeutics, Inc.
 Eliem Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders | Health Technology |
- Stock Market
- Insiders
- Jay Mitchell
